Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
194701011000036118 | Fabrazyme 5 mg powder for injection, 5 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
194702011000036112 | Fabrazyme (agalsidase beta 5 mg) powder for injection, 5 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fabrazyme 5 mg powder for injection, 5 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Fabrazyme 5 mg powder for injection, 5 mg vial | Is a | Fabrazyme | true | Inferred relationship | Some | ||
Fabrazyme 5 mg powder for injection, 5 mg vial | Is a | agalsidase beta 5 mg injection, vial | true | Inferred relationship | Some | ||
Fabrazyme 5 mg powder for injection, 5 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
Fabrazyme 5 mg powder for injection, 5 mg vial | has unit of use | vial | true | Inferred relationship | Some | 2004832481 | |
Fabrazyme 5 mg powder for injection, 5 mg vial | has intended active ingredient | agalsidase beta | true | Inferred relationship | Some | 2004832480 | |
Fabrazyme 5 mg powder for injection, 5 mg vial | has Australian BoSS | agalsidase beta | true | Inferred relationship | Some | 2004832480 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Fabrazyme 5 mg powder for injection, 1 vial | has TPUU | True | Fabrazyme 5 mg powder for injection, 5 mg vial | Inferred relationship | Some | 1 |
Fabrazyme 5 mg powder for injection, 1 vial | has TPUU | True | Fabrazyme 5 mg powder for injection, 5 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Trade product unit of use reference set